Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ZNF134 |
| Upstream (Parents) |
|---|
| (<<) GATA4 → ZNF134 |
| (<<) POU1F1 → ZNF134 |
| (<<) BHLHE41 → ZNF134 |
| (<<) ZNF167 → ZNF134 |
| (<<) GCM1 → ZNF134 |
| (<<) ETV1 → ZNF134 |
| (<<) NKX2-8 → ZNF134 |
| (<<) VAX2 → ZNF134 |
| (<<) CREB3L1 → ZNF134 |
| (<<) MEIS2 → ZNF134 |
| (<<) HNF1A → ZNF134 |
| (<<) ZBTB17 → ZNF134 |
| (<<) EGR3 → ZNF134 |
| (<<) NEUROG1 → ZNF134 |
| (<<) FOXP3 → ZNF134 |
| (<<) ZBTB48 → ZNF134 |
| (<<) VAV1 → ZNF134 |
| (<<) LASS6 → ZNF134 |
| Downstream (Children) |
|---|
| ZNF134 → ZNF135 (>>) |
| ZNF134 → EN1 (>>) |
| ZNF134 → RUNX2 (>>) |
| ZNF134 → FOXA1 (>>) |
| ZNF134 → KLF9 (>>) |
| ZNF134 → CRX (>>) |
| ZNF134 → FOXI1 (>>) |
| ZNF134 → MAX (>>) |
| ZNF134 → RUNX3 (>>) |
